NorthWest Biotherapeutics Inc (NWBO)

[Chiugray]

I think this sixth workstream relates to the PIP. SOW6 has to do with "prerequisites for application" for regulatory approval. In Aug 23rd, NWBO PR'd the approval by MHRA for this PIP (Pediatric Investigation Plan). Having this was a prerequisite for NWBO to apply for regulatory approval with the MHRA.

Then the 10Q says "On September 26, 2022, the Company amended the SOW 6... (2) add a sixth workstream". That makes sense. It takes a month to properly spec out and write an add-on to a SOW. My thinking here: because the PIP is a plan that is required to have in place, it makes sense there is also a signed SOW in place.

Having these signed and in place is consistent with the requirement for "prerequisite". Therefore it is likely a project worked in parallel, and is not a bottleneck. Actually very good news in my opinion. Progress is moving forward point by point expeditiously, and my reading between the lines is: the application for approval was submitted months ago.